Clinical Trial Update: A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis [Phase 3]

View source ↗

Summary

A Phase 3 placebo-controlled trial evaluated two-day pre-treatment with fexofenadine for seasonal allergic rhinitis, and the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Fexofenadine (fexofenadine)

Snippet

Sponsor: Opella Healthcare Group SAS, a Sanofi Company | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2024-05-16